SEC Form 4
American Healthcare REIT, Inc. (AHR) insider trading
In the 12 months to Oct 24, 2026, 3 AHR insiders reported open-market sales of $5.5M across 9 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $5.5M
- 9 filings · 3 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 3 of 9
- $304.5K of $5.5M sold (6%)
Who traded AHR, and when
- Sale
- Sale, pre-arranged (10b5-1)
AHR daily close from Oct 24, 2025 to Oct 23, 2026, between $44.09 and $57.72, last $53.02. 9 sale and 0 purchase filings by 3 insiders, marked at their filing dates. Jeffrey T. Hanson, Director: sold $3.6M across 2 filings, first filed Nov 10, 2025, last Dec 29, 2025. Brian Peay, Chief Financial Officer: sold $1.3M across 1 filing, first filed Jun 29, 2026, last Jun 29, 2026. Mark E. Foster, EVP, GC & Secretary: sold $578.1K across 6 filings, first filed Nov 12, 2025, last Sep 28, 2026.
Largest mark · tap a row for others
Jeffrey T. Hanson · Director
Sale $2,650,400
54,778 shares at $48.38 avg
Filed Dec 29, 2025 · traded Dec 22
Close on filing date $48.30
Jeffrey T. Hanson · Director
Director
$3.6M soldBrian Peay · Chief Financial Officer
Chief Financial Officer
$1.3M soldMark E. Foster · EVP, GC & Secretary
EVP, GC & Secretary
$578.1K soldHas American Healthcare REIT, Inc.'s CEO sold stock?
No. Jeffrey T. Hanson and Danny Prosky (CEOs) made no open-market sales filed as CEO in the last 12 months.
Open-market trades
9 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Jeffrey T. Hanson | Director | $3.6M | — | 2 | — | |
| Brian Peay | Chief Financial Officer | $1.3M | — | 1 | — | |
| Mark E. Foster | EVP, GC & Secretary | $578.1K | — | 6 | 53% of sales |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Mark E. Foster EVP, GC & Secretary | Sale | 1,500 | $52.06 | $78.1K | 50,117 | |
traded | Mark E. Foster EVP, GC & Secretary | SalePre-arranged (10b5-1) | 2,000 | $55.39 | $110.8K | 51,617 | |
traded | Brian Peay Chief Financial Officer | Sale | 25,000 | $50.70 | $1.3M | 152,700 | |
traded | Mark E. Foster EVP, GC & Secretary | Sale | 2,500 | $48.58 | $121.5K | 52,995 | |
traded | Mark E. Foster EVP, GC & Secretary | SalePre-arranged (10b5-1) | 2,000 | $48.32 | $96.6K | 55,495 | |
traded | Mark E. Foster EVP, GC & Secretary | SalePre-arranged (10b5-1) | 2,000 | $48.55 | $97.1K | 56,121 | |
traded | Jeffrey T. Hanson Director | Sale | 54,778 | $48.38 | $2.7M | 0 | |
traded | Mark E. Foster EVP, GC & Secretary | Sale | 1,500 | $49.35 | $74.0K | 57,600 | |
traded | Jeffrey T. Hanson Director | Sale | 20,010 | $49.68 | $994.1K | 21,798 |
GET /stocks/filings/vX/form-4?tickers=AHR&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"AHR"
],
"issuer_cik": "0001632970",
"owner_cik": "0001941750",
"accession_number": "0001193125-26-405369",
"form_type": "4",
"filing_date": "2026-09-28",
"period_of_report": "2026-09-25",
"issuer_name": "American Healthcare REIT, Inc.",
"issuer_trading_symbol": "AHR",
"owner_name": "Foster Mark E.",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "EVP, GC & Secretary",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-25",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 1500,
"transaction_price_per_share": 52.06,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 50117,
"transaction_value": 78090,
"direct_or_indirect": "D"
},
{
"tickers": [
"AHR"
],
"issuer_cik": "0001632970",
"owner_cik": "0001941750",
"accession_number": "0001193125-26-379084",
"form_type": "4",
"filing_date": "2026-09-01",
"period_of_report": "2026-09-01",
"issuer_name": "American Healthcare REIT, Inc.",
"issuer_trading_symbol": "AHR",
"owner_name": "Foster Mark E.",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "EVP, GC & Secretary",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-09-01",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 2000,
"transaction_price_per_share": 55.39,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 51617,
"transaction_value": 110780,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."
},
{
"id": "F2",
"description": "The transaction described herein was made pursuant to an exception to a lock-up agreement between the Reporting Person and the underwriters of the Issuer's offering of shares of common stock that closed on August 12, 2026."
},
{
"id": "F3",
"description": "Includes 622 shares acquired under the Issuer's Employee Stock Purchase Plan."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 58 records
- Option exercises22 records
- Tax withholding28 records
- Grants and awards8 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for AHR every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.